Contribution of Dexamethasone to Control of Chemotherapy-Induced Nausea and Vomiting: A Meta-Analysis of Randomized Evidence
- 19 October 2000
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (19), 3409-3422
- https://doi.org/10.1200/jco.2000.18.19.3409
Abstract
PURPOSE: To synthesize the available randomized evidence on the efficacy of dexamethasone when used for protection against acute and delayed nausea and vomiting in patients receiving highly or mode...Keywords
This publication has 61 references indexed in Scilit:
- An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trialsStatistics in Medicine, 1998
- Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the Perugia Consensus ConferenceAnnals of Oncology, 1998
- Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity.Supportive Care in Cancer, 1998
- Summing up evidence: one answer is not always enoughThe Lancet, 1998
- Quantitative Synthesis in Systematic ReviewsAnnals of Internal Medicine, 1997
- An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomitingEuropean Journal Of Cancer, 1997
- Cumulative meta-analysis of clinical trials builds evidence for exemplary medical careJournal of Clinical Epidemiology, 1995
- Control of Chemotherapy-Induced EmesisNew England Journal of Medicine, 1993
- Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapyThe Lancet, 1991
- An Assessment of Clinically Useful Measures of the Consequences of TreatmentNew England Journal of Medicine, 1988